feed,title,long_url,short_url
Benzinga,Johnson & Johnson's Mid-Stage Lung Cancer Trial Reveals Fewer Infusion-Related Reactions,https://benzinga.com/general/biotech/24/09/40813730/johnson-johnsons-mid-stage-lung-cancer-trial-reveals-fewer-infusion-related-reactions,https://da.gd/lkGKg
